Bosentan, an endothelin receptor antagonist, ameliorates collagen-induced arthritis: The role of TNF-α in the induction of endothelin system genes

Inflammation Research

Volumn 61, Issue 4, 2012, Pages 337-348

  Donate, Paula B ^a   Cunha, Thiago M ^a   Verri Jr , Waldiceu A ^a,b   Junta, Cristina M ^a   Lima, Flavia O ^a   Vieira, Silvio M ^a   Peres, Rafael S ^a   Bombonato Prado, Karina F ^a   Louzada, Paulo ^a   Ferreira, Sergio H ^a   Donadi, Eduardo A ^a   Passos, Geraldo A S ^a   Cunha, Fernando Q ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF LONDRINA   (Brazil)

Author keywords

Bosentan; Collagen induced arthritis; Endothelins; Inflammation; Microarray; Rheumatoid arthritis

Indexed keywords

BOSENTAN; COLLAGEN; ENDOTHELIN; ENDOTHELIN RECEPTOR; INFLIXIMAB; INTERLEUKIN 17; INTERLEUKIN 1BETA; MESSENGER RNA; METHOTREXATE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHROPATHY; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE INDUCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKOCYTE MIGRATION; LYMPH NODE; MALE; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; RHEUMATOID ARTHRITIS; TREATMENT OUTCOME;

ADULT; ANIMALS; ANTIRHEUMATIC AGENTS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; CELLS, CULTURED; CYTOKINES; ENDOTHELIN-1; FEMALE; GENE EXPRESSION PROFILING; HUMANS; LEUKOCYTES, MONONUCLEAR; LYMPH NODES; MALE; METHOTREXATE; MICE; MICE, INBRED DBA; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, ENDOTHELIN; RNA, MESSENGER; SULFONAMIDES;

EID: 84863090697     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-011-0415-5     Document Type: Article

References (52)

1. Arend WP. Physiology of cytokine pathways in rheumatoid arthritis. Arthritis Rheum. 2001;45:101-6.
2. Yamamura YR, Gupta Y, Morita X, He R, Pai J, Endres A, et al. Effector function of resting T cells: activation of synovial fibroblasts. J Immunol. 2001;166:2270-5.
3. Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol. 1996;14:397-440.
4. Lajas C, Abasolo L, Bellajdel B. Costs and predictors of costs in rheumatoid arthritis: a prevalence-based study. Arthritis Rheum. 2003;49:64-70.
5. Christopher JE. Immunological therapies for rheumatoid arthritis. Br Med Bull. 2005;73 and 74:71-82.
6. Feldmann M, Maini RN. Lasker clinical medical research award: TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases. Nat Med. 2003;9:1245-50.
7. 2 channels. J Hypertens. 1988;6:188-91.
8. Rubanyi GM, Polokoff MA. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev. 1988;46:325-415.
9. Dhaun N, Pollock DM, Goddard J, Webb DJ. Selective and mixed endothelin receptor antagonism in cardiovascular disease. Trends Pharmacol Sci. 2007;28:573-9.
10. Inoue A, Yanagisawa M, Kimura S. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci USA. 1989;86:2863-7.
11. Webb DJ, Monge JC, Rabelink TJ, Yanagisawa M. Endothelin: new discoveries and rapid progress in the clinic. Trends Pharmacol Sci. 1998;19:5-8.
12. Ferreira SH, Romitelli M, de Nucci G. Endothelin -1 participation in overt and inflammatory pain. J Cardiovasc Pharmocol. 1989; 5:220-2.
13. Rae GA, Henriques MG. Endothelins in inflammation: proinflammatory and anti-inflammatory peptides. Marcel Dekker: New York; 1998. p. 163-202.
14. Haq A, El-Ramahi K, Al-Dalaan A, Al-Sedairy ST. Serum and synovial fluid concentrations of endothelin-1 in patients with rheumatoid arthritis. J Med. 1999;30(1-2):51-60.
15. Miyasaka N, Hirata Y, Ando K, Sato K, Morita H, Shichiri M, et al. Increased production of endothelin-1 in patients with inflammatory arthritis. Arthritis Rheum. 1992;35:397-400.
16. Yoshida H, Imafuku Y, Ohhara M, Miyata M, Kasukawa R, Ohsumi K, et al. Endothelin-1 production by human synoviocytes. Ann Clin Biochem. 1998;35(2):290-4.
17. Wharton J, Rutherford RA, Walsh DA, Mapp PI, Knock GA, Blake DR, et al. Autoradiographic localization and analysis of endothelin-1 binding sites in human synovial tissue. Arthritis Rheum. 1992;35(8):894-9.
18. Marjolaine RB, Johanne MP, Jean-Pierre P, Khatija NM, Stephan C, Fazool S, et al. Endothelin 1 promotes osteoarthritic cartilage degradation via matrix metalloprotease 1 and matrix metalloprotease 13 induction. Arthritis Rheum. 2003;48(10):2855-64.
19. Imhof AK, Gluck L, Gajda M, Brauer R, Schaible H, Schulz S. Potent antiinflammatory and antinociceptive activity of the endothelin receptor antagonist bosentan in monoarthritic mice. Arthritis Res Ther. 2001;13(3):R97.
20. Leung BP, Sattar N, Crilly A, Prach M, McCarey DW, Payne H, et al. A novel anti-inflammatory role for simvastatin in inflammatory arthritis. J Immunol. 2003;170:1524-30.
21. Lagares D, García-Fernández RA, Jiménez CL, Magán-Marchal N, Busnadiego O, Lamas S, et al. Endothelin 1 contributes to the effect of transforming growth factor β1 on wound repair and skin fibrosis. Arthritis Rheum. 2010;62(3):878-89.
22. Verri WA Jr, Cunha T, Magro DA, Guerrero ATG, Vieira SM, Carregaro V, et al. Targeting endothelin ETA and ETB receptors inhibits antigen-induced neutrophil migration and mechanical hypernociception in mice. Naunyn-Schmiedeberg's Arch Pharmacol. 2008;379:271-9.
23. Verri WA Jr, Guerrero AT, Fukada SY, Valerio DA, Cunha TM, Xu D, et al. IL-33 mediates antigen-induced cutaneous and articular hypernociception in mice. Proc Natl Acad Sci USA. 2008;105(7):2723-8.
24. Cunha TM, Verri WA Jr, Poole S, Parada CA, Cunha FQ, Ferreira SH. Pain facilitation by proinflammatory cytokine actions at peripheral nerve terminals. In: DeLeo J, Sorkin L, Watkins L, editors. Immune and glial regulation of pain. Seattle: IASP; 2007. p. 67-83.
25. Cunha TM, Verri WA Jr, Vivancos GG, Moreira IF, Reis S, Parada CA. An electronic pressure-meter nociception paw test for mice. Braz J Med Biol Res. 2004;37:401-7.
26. Cunha TM, Verri WA Jr, Silva JS, Poole S, Cunha FQ, Ferreira SH. A cascade ofcytokines mediates mechanical inflammatory hypernociception in mice. Proc Natl Acad Sci USA. 2005; 102(5):1755-60.
27. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315-24.
28. Prevoo ML, Van't Hof MA, Kuper HH, Van Leeuwen MA, Van de Putte LB, Van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995;38:44-8.
29. Hegde P, Qi R, Abernathy K, Gay C, Dharap S, Gaspard R, et al. A concise guide to cDNA microarray analysis. Biotechniques. 2000;29(3):548-56.
30. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA. 2001;98(9):5116-21.
31. Eisen MB, Spellmam PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA. 1998;95:14863-8.
32. Denton CP. Therapeutic targets in systemic sclerosis. Arthritis Res Ther. 2007;9(2):S6.
33. Mayes MD. Endothelin and endothelin receptors antagonists in systemic rheumatic disease. Arthritis Rheum. 2003;48:1190-9.
34. Bendele A. Animal models of rheumatoid arthritis. J Musculoskelet Neuronal Interact. 2001;1:377-85.
35. Conte FP, Barja-Fidalgo C, Verri WA Jr, Cunha FQ, Rae GA, Penido C, et al. Endothelins modulate inflammatory reaction in Zymosan induced arthritis: participation of LTB4, TNFα, and CXCL-1. J Leukocyte Biol. 2008;84:652-60.
36. Pinto LG, Cunha TM, Vieira SM, Lemos HP, WA VerriJ, Cunha FQ, et al. IL-17 mediates articular hypernociception in antigeninduced arthritis in mice. Pain. 2010;148(2):247-56.
37. Shaffer AL, Wright G, Yang L, Powell J, Ngo V, Lamy L, Lam LT, et al. A library of gene expression signatures to illuminate normal and pathological lymphoid biology. Immunol Rev. 2006;210:7-85.
38. Yamagata T, Benoist C, Mathis DA. Shared gene-expression signature in innate-like lymphocytes. Immunol Rev. 2006;210: 52-66.
39. Lequerre T, Coulouarn C, Derambure C, Lefebvre G, Vittecoq O, Daveau M. A new tool for rheumatology: large-scale analysis of gene expression. Joint Bone Spine. 2003;70:248-56.
40. Barman SA, Marrero MB. Mechanism of endothelin-1 activation of map kinases in neonatal pulmonary vascular smooth muscle. Lung. 2005;183:425-39.
41. Khodorova A, Montmayeur JP, Strichartz G. Endothelin receptors and pain. J Pain. 2009;10:4-28.
42. Patel DD, Zachariah JP, Whichard LP. CXCR3 and CCR5 ligands in rheumatoid arthritis synovium. Clin Immunol. 2001; 98:39-45.
43. Robinson E, Keystone EC, Schall TJ, Gillett N, Fish EN. Chemokine expression in rheumatoid arthritis (RA): evidence of RANTES and macrophage inflammatory protein (MIP)-1 beta production by synovial T cells. Clin Exp Immunol. 1995;101: 398-407.
44. Thornton S, Duwel LE, Boivin GP, Ma Y, Hirsch R. Association of the course of collagen-induced arthritis with distinct patterns of cytokine and chemokine messenger RNA expression. Arthritis Rheum. 1999;42:1109-18.
45. Agyekum S, Church A, Sohail M, Krausz T, Van Noorden S, Polak J. Expression of lymphotoxin-beta (LT-Beta) in chronic inflammatory conditions. J Pathol. 2002;199:115-21.
46. Lu G, Janjic BM, Janjic J, Whiteside TL, Storkus WJ, Vujanovic NL. Innate direct anticancer effector function of human immature dendritic cells. II. Role of TNF, lymphotoxin-alpha(1)beta(2), Fas ligand, and TNF-related apoptosis-inducing ligand. J Immunol. 2002;168:1831-9.
47. Rennert PD, James D, Mackay F, Browning JL, Hochman PS. Lymph node genesis is induced by signaling through the lymphotoxin beta receptor. Immunity. 1998;9:71-9.
48. Takemura S, Braun A, Crowson C, Kurtin PJ, CoWeld RH, O'Fallon WM. Lymphoid neogenesis in rheumatoid synovitis. J Immunol. 2001;167:1072-80.
49. Guruli G, Pflug BR, Pecher S, Makarenkova V, Shurin MR, Nelson JB. Function and survival of dendritic cells depend on endothelin-1 and endothelin receptor autocrine loops. Blood. 2004;104(7):2107-15.
50. Kurihara H, Yoshizumi M, Sugiyama T, Takaku F, Yanagisawa M. Transforming growth factor-beta stimulates the expression of endothelin mRNA by vascular endothelial cells. Biochem Biophys Res Commun. 1989;159:1435-40.
51. Lattmann T, Hein M, Horber S, Ortmann J. Activation of proinflammatory and anti-inflammatory cytokines in host organs during chronic allograft rejection: role of endothelin receptor signaling. Am J Transplant. 2005;5:1042-9.
52. Marsden PA, Brenner BM. Regulation of ET-1 gene by TNF-α. Am J Physiol. 1992;262:854-61.